# Air Versus Oxygen for Intermediate-Risk Pulmonary Embolism (AIRE)

> **NCT04003116** · PHASE3 · COMPLETED · sponsor: **Ministry of Health, Spain** · enrollment: 70 (actual)

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** Oxygen gas

## Key facts

- **NCT ID:** NCT04003116
- **Lead sponsor:** Ministry of Health, Spain
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-11
- **Primary completion:** 2022-04-24
- **Final completion:** 2022-07-25
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2022-08-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04003116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04003116, "Air Versus Oxygen for Intermediate-Risk Pulmonary Embolism (AIRE)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04003116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*